latest news on glp 1 glp-1 Researchers find medications safe to continue before surgery in patients with diabetes and obesity Fmr. FDA Commissioner weighs in – Lipsitz, Ponterio & Comerford |

It comes down to what you are willing to tolerate for the outcomes you need

showed that it could reduce food intake, gastric emptying, body weight, liver function tests (LFTs), and glucose levels in a dose-dependent manner, thus improving hepatic insulin sensitivity and hepatic steatosis

C.FleckP

Genuinely effective obesity drugs, as GLP-1s appear to be, should have a positive impact on the bottom line of US health insurers like Cigna (CI), United Healthcare (UNH), Humana (HUM) and Centene (CNC) in the long term while harming companies paying for these very expensive and likely to be in-demand medications like Insperity (NSP) and Robert Half (RHI)

Long-term monitoring after getting off GLP-1 The monitoring does not end after 90 days